Hvidovre Hospital

6 trials 3 recruiting Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

3 Recruiting

2 Completed trials

1 Countries active

38 Unique IMPs

100% Results reported

Phase II

Phase I/II

Phase III/IV

Phase IV

Phase II: 2 Phase I/II: 1 Phase III/IV: 1 Phase IV: 2

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

AMIKACIN 1 BENZYLPENICILLIN SODIUM 1 CEFOTAXIME 1 CEFTRIAXONE 1 CEFUROXIME SODIUM 1 CLARITHROMYCIN 1 CLINDAMYCIN 1 CLOXACILLIN SODIUM 1 DAPTOMYCIN 1 DICLOXACILLIN 1 ERTAPENEM SODIUM 1 FLUCLOXACILLIN 1

All trials

6 total

MENPI: Safety and immunogenicity following meningococcal and pneumococcal immunization among adult people living with HIV. A single center, … Pending

2024-516961-35-01 Phase III/IV 1 country
Pharmacokinetics, safety, and efficacy of fisetin - A phase I and pilot phase IIa study Recruiting

2023-506284-34-00 Phase I/II 1 country
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country AMIKACIN; BENZYLPENICILLIN SODIUM; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME SODIUM; C…
Hydroxychloroquine treatment for Recurrent Pregnancy Loss: a randomized double-blind placebo-controlled trial Recruiting

2024-515579-36-00 Phase II 1 country HYDROXYCHLOROQUINE SULFATE
Orismilast for the treatment of moderate to severe ulcerative colitis Ended

2022-502763-37-02 Phase II 1 country ORISMILAST
Clinical trial on Spinal Anaesthesia vs. General Anaesthesia (SAGA) on recovery after hip and knee replacements Ended

2022-501221-21-00 Phase IV 1 country

Showing 1–6 of 6 trials

← All sponsors A–Z